Archives
-
Sunil Shah, CEO of o2h ventures, wins the Cambridge Independent Science and Technology Awards as CEO of the Year
16 April, 2021
-
University of Sussex and o2h Ventures Announce Creation and Investment in Stingray Bio, a Company for New Oncology Drugs Targeting the LMTK3 Kinase Pathway
08 April, 2021
-
The o2h human health S/EIS flagship fund – Fully Deployed
01 April, 2021
-
o2h Ventures invests into SomaServe’s successful Series A funding round
31 March, 2021
-
o2h Ventures invests in PhoreMost Series B financing
23 March, 2021
-
Building Britain into a Scientific Superpower…
03 March, 2021
-
o2h Human Health EIS Fund leads an investment into Kuano, using quantum and AI to accelerate the development of new medicine.
25 February, 2021
-
o2h Ventures invests into the UCL spin out company SomaServe.
22 February, 2021
-
o2h ventures leads the funding into Cambridge University Biotech Spinout Spirea
07 December, 2020